App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

NCT06367257 · tracked via the Priya Life Science Germany tracker

Sponsor

University of Erlangen-Nürnberg Medical School

Phase

Not applicable

Started

2024-02-29

Last updated

2026-07-31

Condition(s) studied

Squamous Cell Carcinoma of Head and Neck

Investigational drug(s) / intervention(s)

App UsageStandard of Care

App Usage: Conducting patient surveys with app

Standard of Care: supportive care during and after radio(chemo)therapy according to hospial standards

Study summary

Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients with squamous cell carcinoma in the head and neck region, who receive a postsurgical or definitive radio(chemo)therapy * Patients who have a smartphone on which the Emento app can be installed * Minimum age 18 years Exclusion Criteria: * Patients who are represented by a legal guardian * Patients who are not suitable for participation in the study due to a language barrier

Primary outcome measure(s)

Change in rates of weight loss with additional app-based Patient Care — during trial, about 24 months

Trial sites (1)

Facility	City	Region	Status
Universitätsklinikum Erlangen, Strahlenklinik	Erlangen	Bavaria	Recruiting

More University of Erlangen-Nürnberg Medical School trials in Germany

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases Recruiting

Immune Biomarker Study for Salivary Gland Carcinoma Recruiting

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial Recruiting

Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine Recruiting

Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis Recruiting

Other trials for the same condition

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer Recruiting

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06367257 on ClinicalTrials.gov ↗ ← All trials in Germany